Family Promise: Get Tested for Hepatitis B
Video by CDC & Hep B United
Last Updated on July 24, 2023 by HepFree NYC
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
Family Promise: Get Tested for Hepatitis B
Video by CDC & Hep B United
Last Updated on July 24, 2023 by HepFree NYC
Find resources, testing, and medical care for those who are co-infected with HIV and Hep C.
Join the #FundHep social media campaign in an effort to advocate for more Federal funds for hepatitis in FY2017!
On October 10, 2014, FDA approved HARVONI a fixed-dose combination tablet of ledipasvir 90 mg, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir 400 mg, an HCV nucleotide analog NS5B polymerase inhibitor. Harvoni is indicated for the treatment of chronic hepatitis C (CHC) ...
In March 2020, the United States Preventive Services Task Force recommended one-time screening for hepatitis C in people aged 18-79. Simplified treatment guidance has been developed for hepatitis B and C.
FDA Approves Viekira Pak to Treat Hep C A new hepatitis C medication, Viekira Pak, was approved today by the U.S. Food and Drug Administration (FDA). AbbVie, who markets the drug, has not immediately released the price of the new all-oral Hep C medication which will now rival Ha...
The FDA has approved the drug Epclusa to treat adult patients with chronic Hep C both with and without cirrhosis.
Committee members educate the public about Hepatitis through presentations, tabling at health fairs, and distribution of resources throughout at-risk communities.
Plan sets forth strategies to reduce new Hep C infections by 90%, premature deaths among people with Hep B & Hep C by 65%, and health inequities related to viral hepatitis. Health Department to partner with Hep Free NYC coalition on plan implementation.

We (hepfree.nyc) and selected third parties (7) collect personal information as specified in the privacy policy and use cookies or similar technologies for technical purposes and, with your consent, for functionality, experience, measurement and marketing (personalized ads).
You can freely give, deny, or withdraw your consent at any time by accessing the preferences panel. Denying consent may make related features unavailable.
Use the "Accept all" button to consent. Use the "Reject all" button to continue without accepting.
In this panel you can express preferences for the processing of your personal information. You may review and change your choices at any time.